Business Segments · Total Assets
Consumer Tissue — Total Assets
Kimberly-Clark Consumer Tissue — Total Assets decreased by 2.2% to $4.94B in Q4 2023 compared to the prior quarter.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ4 2022
Last reportedQ1 2026
Rolls up toTotal Assets
How to read this metric
Growth in assets relative to revenue can indicate changes in capital efficiency or expansion.
Detailed definition
The total value of all resources controlled by the Consumer Tissue segment, including inventory, property, plant, equipm...
Peer comparison
Standard balance sheet metric for segment-level reporting.
Metric ID:
kmb_segment_consumer_tissue_assetsHistorical Data
3 periods
| Q4 '21 | Q4 '22 | Q4 '23 | |
|---|---|---|---|
| Value | $5.08B | $5.05B | $4.94B |
| QoQ Change | — | -0.7% | -2.2% |
| YoY Change | — | -0.7% | -2.2% |
Range$4.94B – $5.08B
Avg YoY Growth-1.5%
Median YoY Growth-1.5%
Current Streak2+ quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Kimberly-Clark's consumer tissue — total assets?
- Kimberly-Clark (KMB) reported consumer tissue — total assets of $4.94B in Q4 2023.
- What does consumer tissue — total assets mean?
- The total value of all assets owned and used by the Consumer Tissue business segment.